SE9401727D0 - New compounds I - Google Patents
New compounds IInfo
- Publication number
- SE9401727D0 SE9401727D0 SE9401727A SE9401727A SE9401727D0 SE 9401727 D0 SE9401727 D0 SE 9401727D0 SE 9401727 A SE9401727 A SE 9401727A SE 9401727 A SE9401727 A SE 9401727A SE 9401727 D0 SE9401727 D0 SE 9401727D0
- Authority
- SE
- Sweden
- Prior art keywords
- alkyl
- hydrogen
- group
- pct
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9401727A SE9401727D0 (sv) | 1994-05-18 | 1994-05-18 | New compounds I |
IL11362795A IL113627A0 (en) | 1994-05-18 | 1995-05-07 | New agonist compounds |
ZA953699A ZA953699B (en) | 1994-05-18 | 1995-05-08 | New agonist compounds |
NZ287177A NZ287177A (en) | 1994-05-18 | 1995-05-09 | Morphinane derivatives; medicaments |
EP95920329A EP0759923A1 (en) | 1994-05-18 | 1995-05-09 | New agonist compounds |
CN95194032A CN1152314A (zh) | 1994-05-18 | 1995-05-09 | 新的***化合物 |
US08/507,365 US5886001A (en) | 1994-05-18 | 1995-05-09 | Agonist compounds |
JP7529554A JPH10500132A (ja) | 1994-05-18 | 1995-05-09 | 新規なアゴニスト化合物 |
SK1396-96A SK139696A3 (en) | 1994-05-18 | 1995-05-09 | New agonist compounds |
CA002189139A CA2189139A1 (en) | 1994-05-18 | 1995-05-09 | New agonist compounds |
PCT/SE1995/000504 WO1995031464A1 (en) | 1994-05-18 | 1995-05-09 | New agonist compounds |
AU25818/95A AU690281B2 (en) | 1994-05-18 | 1995-05-09 | New agonist compounds |
PL95317250A PL317250A1 (en) | 1994-05-18 | 1995-05-09 | Novel agonistic compounds |
HU9603171A HU9603171D0 (en) | 1994-05-18 | 1995-05-09 | New agonist compounds |
BR9507656A BR9507656A (pt) | 1994-05-18 | 1995-05-09 | Composto utilização de um composto composição farmacéutica e processos para o tratamento de um paciente que sofre de dor e para a preparação de um composto |
IS4381A IS4381A (is) | 1994-05-18 | 1996-11-08 | Ný gerandefni |
NO964871A NO964871L (no) | 1994-05-18 | 1996-11-15 | Nye agonistforbindelser |
FI964576A FI964576A0 (sv) | 1994-05-18 | 1996-11-15 | Nya agonistföreningar |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9401727A SE9401727D0 (sv) | 1994-05-18 | 1994-05-18 | New compounds I |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9401727D0 true SE9401727D0 (sv) | 1994-05-18 |
Family
ID=20394058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9401727A SE9401727D0 (sv) | 1994-05-18 | 1994-05-18 | New compounds I |
Country Status (18)
Country | Link |
---|---|
US (1) | US5886001A (sv) |
EP (1) | EP0759923A1 (sv) |
JP (1) | JPH10500132A (sv) |
CN (1) | CN1152314A (sv) |
AU (1) | AU690281B2 (sv) |
BR (1) | BR9507656A (sv) |
CA (1) | CA2189139A1 (sv) |
FI (1) | FI964576A0 (sv) |
HU (1) | HU9603171D0 (sv) |
IL (1) | IL113627A0 (sv) |
IS (1) | IS4381A (sv) |
NO (1) | NO964871L (sv) |
NZ (1) | NZ287177A (sv) |
PL (1) | PL317250A1 (sv) |
SE (1) | SE9401727D0 (sv) |
SK (1) | SK139696A3 (sv) |
WO (1) | WO1995031464A1 (sv) |
ZA (1) | ZA953699B (sv) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU712012B2 (en) * | 1995-09-26 | 1999-10-28 | Toray Industries, Inc. | Indole derivatives and medical application thereof |
NZ331769A (en) * | 1997-01-16 | 2000-05-26 | Toray Industries | Indolomorphinan derivative and agent for curing and preventing cerebral disorder |
GB9717629D0 (en) * | 1997-08-21 | 1997-10-22 | Johnson Matthey Plc | Removal of residual organic solvents |
WO2000008027A1 (en) * | 1998-08-06 | 2000-02-17 | Regents Of The University Of Minnesota | Kappa (op2) opioid receptor antagonists |
US7232829B2 (en) | 2001-04-06 | 2007-06-19 | Regents Of The University Of Minnesota | Therapeutic compounds and methods |
WO2002080919A1 (en) * | 2001-04-06 | 2002-10-17 | Regents Of The University Of Minnesota | Therapeutic compounds and methods |
DE10229842A1 (de) * | 2002-07-03 | 2004-02-05 | Helmut Prof. Dr. Schmidhammer | Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung |
NZ546834A (en) | 2003-10-01 | 2010-03-26 | Adolor Corp | Spirocyclic heterocyclic derivatives and methods of their use |
US7598261B2 (en) | 2005-03-31 | 2009-10-06 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
US7576207B2 (en) | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
WO2008033299A2 (en) | 2006-09-12 | 2008-03-20 | Adolor Corporation | Use of n-containing spirocompounds for the enhancement of cognitive function |
US9321116B2 (en) * | 2009-03-05 | 2016-04-26 | United Technologies Corporation | Cold metal transfer gas metal arc welding apparatus and method of operation |
EP2340832A1 (en) | 2009-12-23 | 2011-07-06 | Universität Innsbruck | Morphinan-6-one compounds for the treatment or prevention of neurodegenerative diseases |
CA2822453C (en) * | 2010-12-23 | 2019-04-02 | Phoenix Pharmalabs, Inc. | Novel morphinans useful as analgesics |
WO2014037832A2 (en) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment of epilepsy and neurological diseases |
WO2013168021A1 (en) | 2012-05-07 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders |
US9399634B2 (en) | 2012-05-07 | 2016-07-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of depression |
CA2872975A1 (en) | 2012-05-07 | 2013-11-14 | Cellixbio Private Limited | Compositions and methods for the treatment of neurological disorders |
WO2013168025A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of blood clotting disorders |
WO2013167992A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of inflammatory disorders |
WO2013168023A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of parkinson's disease |
WO2013167991A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic disorders |
WO2013167993A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurological degenerative disorders |
US9339484B2 (en) | 2012-05-10 | 2016-05-17 | Cellix Bio Private Limited | Compositions and methods for the treatment of restless leg syndrome and fibromyalgia |
WO2013168012A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of respiratory disorders |
WO2013168033A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of neurologic diseases |
WO2013168001A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
US9403857B2 (en) | 2012-05-10 | 2016-08-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
WO2013168014A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of familial amyloid polyneuropathy |
WO2013168002A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurological conditions |
WO2013168011A1 (en) * | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of chronic pain |
US9394288B2 (en) | 2012-05-10 | 2016-07-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of asthma and allergy |
US9346742B2 (en) | 2012-05-10 | 2016-05-24 | Cellix Bio Private Limited | Compositions and methods for the treatment of fibromyalgia pain |
US9573927B2 (en) | 2012-05-10 | 2017-02-21 | Cellix Bio Private Limited | Compositions and methods for the treatment of severe pain |
WO2013167999A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurologic diseases |
US9315478B2 (en) | 2012-05-10 | 2016-04-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
WO2013175376A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of local pain |
WO2013175347A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of respiratory disorders |
CA2873096A1 (en) | 2012-05-23 | 2013-11-28 | Cellixbio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
US9434729B2 (en) | 2012-05-23 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of periodontitis and rheumatoid arthritis |
CN104583182A (zh) | 2012-05-23 | 2015-04-29 | 塞利克斯比奥私人有限公司 | 用于治疗粘膜炎的组合物和方法 |
JP2015518854A (ja) | 2012-05-23 | 2015-07-06 | セリックスビオ プライヴェート リミテッド | 多発性硬化症の治療のための組成物および方法 |
US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
US9187427B2 (en) | 2012-08-03 | 2015-11-17 | Cellix Bio Private Limited | N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases |
WO2014037833A2 (en) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment inflammation and lipid disorders |
SG11201407325YA (en) | 2012-09-08 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for treatment of inflammation and lipid disorders |
HU231191B1 (hu) | 2013-04-15 | 2021-08-30 | Szegedi Tudományegyetem | Izotóp tartalmú morfin molekulák |
US9333187B1 (en) | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
WO2014195961A1 (en) | 2013-06-04 | 2014-12-11 | Mahesh Kandula | Compositions and methods for the treatment of diabetes and pre-diabetes |
WO2015082932A1 (en) | 2013-12-05 | 2015-06-11 | The University Of Bath | Novel opioid compounds and their uses |
US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
SG11201706952VA (en) | 2014-09-26 | 2017-10-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of epilepsy and neurological disorders |
EP3201168B1 (en) | 2014-09-29 | 2020-03-18 | Cellix Bio Private Limited | Compounds and compositions for the treatment of multiple sclerosis |
EP3212626B1 (en) | 2014-10-27 | 2018-11-07 | Cellix Bio Private Limited | Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis |
US9321716B1 (en) | 2014-11-05 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9173877B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
US9175008B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Prodrugs of anti-platelet agents |
US10208014B2 (en) | 2014-11-05 | 2019-02-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
US9284287B1 (en) | 2014-11-05 | 2016-03-15 | Cellix Bio Private Limited | Compositions and methods for the suppression of carbonic anhydrase activity |
US9290486B1 (en) | 2014-11-05 | 2016-03-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy |
US9150557B1 (en) | 2014-11-05 | 2015-10-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of hyperglycemia |
WO2016073615A1 (en) | 2014-11-07 | 2016-05-12 | Regents Of The University Of Minnesota | Salts and compositions useful for treating disease |
US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9206111B1 (en) | 2014-12-17 | 2015-12-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological diseases |
CN110845355A (zh) | 2015-01-06 | 2020-02-28 | 塞尔利克斯生物私人有限公司 | 用于治疗炎症和疼痛的组合物和方法 |
JP2019509321A (ja) | 2016-03-22 | 2019-04-04 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | 疼痛を処置するための組み合わせ |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816586A (en) * | 1987-07-29 | 1989-03-28 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists |
JP2906654B2 (ja) * | 1989-11-28 | 1999-06-21 | 東レ株式会社 | 免疫抑制剤及びその製造方法 |
US5223507A (en) * | 1992-01-21 | 1993-06-29 | G. D. Searle & Co. | Method of using opioid compounds as delta opioid selective agonist analgesics |
US5225417A (en) * | 1992-01-21 | 1993-07-06 | G. D. Searle & Co. | Opioid agonist compounds |
WO1993015081A1 (fr) * | 1992-01-23 | 1993-08-05 | Toray Industries, Inc. | Derive de morphinane et utilisation en medicine |
CN1043766C (zh) * | 1992-09-29 | 1999-06-23 | 东丽株式会社 | 吲哚衍生物及其制法和它们在制备药物中的应用 |
US5464841A (en) * | 1993-11-08 | 1995-11-07 | Univ Minnesota | Use of delta opioid receptor antagonists to treat immunoregulatory disorders |
US5780479A (en) * | 1997-04-04 | 1998-07-14 | Regents Of The University Of Minnesota | Use of opioid antagonists to treat impulse-control disorders |
-
1994
- 1994-05-18 SE SE9401727A patent/SE9401727D0/sv unknown
-
1995
- 1995-05-07 IL IL11362795A patent/IL113627A0/xx unknown
- 1995-05-08 ZA ZA953699A patent/ZA953699B/xx unknown
- 1995-05-09 NZ NZ287177A patent/NZ287177A/en unknown
- 1995-05-09 JP JP7529554A patent/JPH10500132A/ja not_active Abandoned
- 1995-05-09 EP EP95920329A patent/EP0759923A1/en not_active Withdrawn
- 1995-05-09 CA CA002189139A patent/CA2189139A1/en not_active Abandoned
- 1995-05-09 AU AU25818/95A patent/AU690281B2/en not_active Ceased
- 1995-05-09 HU HU9603171A patent/HU9603171D0/hu unknown
- 1995-05-09 US US08/507,365 patent/US5886001A/en not_active Expired - Fee Related
- 1995-05-09 PL PL95317250A patent/PL317250A1/xx unknown
- 1995-05-09 SK SK1396-96A patent/SK139696A3/sk unknown
- 1995-05-09 CN CN95194032A patent/CN1152314A/zh active Pending
- 1995-05-09 BR BR9507656A patent/BR9507656A/pt not_active Application Discontinuation
- 1995-05-09 WO PCT/SE1995/000504 patent/WO1995031464A1/en not_active Application Discontinuation
-
1996
- 1996-11-08 IS IS4381A patent/IS4381A/is unknown
- 1996-11-15 NO NO964871A patent/NO964871L/no not_active Application Discontinuation
- 1996-11-15 FI FI964576A patent/FI964576A0/sv unknown
Also Published As
Publication number | Publication date |
---|---|
BR9507656A (pt) | 1997-09-23 |
CA2189139A1 (en) | 1995-11-23 |
FI964576A (sv) | 1996-11-15 |
IL113627A0 (en) | 1995-08-31 |
NO964871D0 (no) | 1996-11-15 |
AU2581895A (en) | 1995-12-05 |
CN1152314A (zh) | 1997-06-18 |
IS4381A (is) | 1996-11-08 |
NO964871L (no) | 1996-11-15 |
FI964576A0 (sv) | 1996-11-15 |
HU9603171D0 (en) | 1997-01-28 |
SK139696A3 (en) | 1997-05-07 |
US5886001A (en) | 1999-03-23 |
PL317250A1 (en) | 1997-04-01 |
AU690281B2 (en) | 1998-04-23 |
EP0759923A1 (en) | 1997-03-05 |
JPH10500132A (ja) | 1998-01-06 |
WO1995031464A1 (en) | 1995-11-23 |
NZ287177A (en) | 1997-11-24 |
ZA953699B (en) | 1995-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9401727D0 (sv) | New compounds I | |
ZA842185B (en) | New n-aryl-n'-cycloalkylalkanoyl-piperazine and process for the production thereof | |
ATE319680T1 (de) | Substituierte 2-benzylamino-2-phenyl- acetamidverbindungen | |
NO964698L (no) | Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase | |
ES497426A0 (es) | Un procedimiento para preparar un compuesto de quinazolina | |
DK1000034T3 (da) | Substituerede 6-alkylphenanthridiner | |
ES2010284A6 (es) | Procedimiento para preparar derivados de tiourea. | |
TW340109B (en) | Amide derivatives and their therapeutic use | |
FI951555A (sv) | 5H,10H-imidazo[1,2-a]indeno[1-2e]pyratsin-4-onderivat, deras framställning och läkemedel | |
ES472290A1 (es) | Un procedimiento para preparar un compuesto de benceno di- sustituido en orto | |
NO961404L (no) | 4-indolylpiperazinyl-derivater | |
DK0689534T3 (da) | Amidderivater som 5-HT1A-ligander | |
CO5040091A1 (es) | Derivados de urea | |
NZ501982A (en) | N-oxide forms of 2,4,4-trisubstituted-1,3-dioxolane as anti-fungal agents | |
IL115085A0 (en) | Bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them | |
ES8609322A1 (es) | Un procedimiento de obtencion de imidazoquinolinas | |
EA199700200A1 (ru) | Способы ингибирования рака яичника | |
TW282458B (sv) | ||
DE69327760T2 (de) | Hydroxyaryl enthaltenden aminocarboxylsäure-chelatbildnern | |
GR3006582T3 (sv) | ||
FI850593L (fi) | N-(2,6-disubstituerade aromatiska) -n'-pyridinylureafoereningar. | |
GB1497827A (en) | Triazolobenzodiazepine derivatives | |
IT1256023B (it) | Derivati benzossazinonici e benzotiazinonici ad attivita' cardiovascolare | |
AU579416B2 (en) | 3-Amino-2,3-dihydro-1-benzoxepine-compounds and methods for their preparation and pharmaceutical preparations containing these compounds | |
IT1206451B (it) | Esteri basici ad attivita'calcioantagonista, procedimenti per la loro preparazione e relative composizioni farmaceutiche. |